58
Pharma & HealthcareHold
DSP Healthcare
DSP · Direct–Growth · rank #6 of 19 by Smart Score
Data updated
Trailing returns
1 Year
19.1%
+18.3% vs index
3 Years
20.6%
+9.0% vs index
5 Years
16.9%
+6.9% vs index
Since launch
22.9%
Year-by-year performance
2021
+25.1%-5.5% vs index
2022
-6.5%-10.3% vs index
2023
+36.8%+10.3% vs index
2024
+42.6%+27.0% vs index
2025
-4.5%-12.2% vs index
2026
+19.6%+18.7% vs index
Why this score
DSP Healthcare scores 58/100 — #6 of 19 Pharma & Healthcare fund (Hold). It stands out for expense ratio and fund size — beating 92% of peers on expense ratio. The main drag is its alpha (better than only 34% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
Expense ratio0.75% · 92nd percentile in category
Fund size3726.51 Cr · 82nd percentile in category
Sharpe ratio1.01 · 66th percentile in category
Alpha3.24 · 34th percentile in category
Sortino ratio1.54 · 63rd percentile in category
5Y return16.95% · 55th percentile in category
Top holdings
1.Apollo Hospitals Enterprise Ltd7.89%
2.Ipca Laboratories Ltd7.49%
3.Cipla Ltd7.4%
4.Sun Pharmaceutical Industries Ltd7.32%
5.Gland Pharma Ltd6.61%
32 disclosed equity positions · portfolio as of Oct 2026 · weights are % of total corpus.